Vimarsana
Biggest News Aggregation in the World

Page 6 - Abstracts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abstracts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abstracts Today - Breaking & Trending Today

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress - Vimarsana News

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology Annual Meeting held... | May 25, 2023

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress - Vimarsana News

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress

Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in high-risk follicular lymphoma Poster presentations will highlight epcoritamab in lymphoma

Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023 - Vimarsana News

Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023

9 poster presentations and 3 abstracts publications reinforce Galapagos' commitment to immunology and the rheumatoid arthritis patient and healthcare professional communityNew analyses will be... | May 22, 2023

Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases - Vimarsana News

Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseasesNew data emphasizes the consistent benefit of Bylvay as an... | May 17, 2023

Mirum Pharmaceuticals to Showcase LIVMARLI Data at ESPGHAN Annual Meeting - Vimarsana News

Mirum Pharmaceuticals to Showcase LIVMARLI Data at ESPGHAN Annual Meeting

Seven abstracts accepted including four oral presentations Phase 3 MARCH PFIC data selected as one of highest scoring abstracts and will be presented during the plenary session on May 18 RISE... | May 17, 2023